BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26088650)

  • 1. Adrenal Imaging Features Predict Malignancy Better than Tumor Size.
    Yoo JY; McCoy KL; Carty SE; Stang MT; Armstrong MJ; Howell GM; Bartlett DL; Tublin ME; Yip L
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S721-7. PubMed ID: 26088650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adrenal mass: correlation of histopathology with imaging.
    Yip L; Tublin ME; Falcone JA; Nordman CR; Stang MT; Ogilvie JB; Carty SE; Yim JH
    Ann Surg Oncol; 2010 Mar; 17(3):846-52. PubMed ID: 19960266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of incidentally discovered adrenal masses and risk of malignancy.
    Favia G; Lumachi F; Basso S; D'Amico DF
    Surgery; 2000 Dec; 128(6):918-24. PubMed ID: 11114624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of adrenal adenoma and nonadenoma in unenhanced CT: new optimal threshold value and the usefulness of size criteria for differentiation.
    Park SH; Kim MJ; Kim JH; Lim JS; Kim KW
    Korean J Radiol; 2007; 8(4):328-35. PubMed ID: 17673844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adrenal incidentaloma: proposal for a correct treatment].
    Favia G; Lumachi F; Gregianin M; Polistina F; Borsato S; D'Amico DF
    Ann Ital Chir; 1997; 68(4):517-22. PubMed ID: 9494183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of concomitant malignancy in hyperfunctioning adrenal incidentalomas.
    Allan BJ; Thorson CM; Van Haren RM; Parikh PP; Lew JI
    J Surg Res; 2013 Sep; 184(1):241-6. PubMed ID: 23562276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is MRI more accurate than CT in estimating the real size of adrenal tumours?
    Kouriefs C; Mokbel K; Choy C
    Eur J Surg Oncol; 2001 Aug; 27(5):487-90. PubMed ID: 11504521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting adrenal mass size as an indication for adrenalectomy.
    Ballian N; Adler JT; Sippel RS; Chen H
    J Surg Res; 2009 Sep; 156(1):16-20. PubMed ID: 19592028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonfunctional adrenal lesions without loss of signal intensity on MRI: whose problem is it? The patient's? The surgeon's?
    Aksakal N; Şahbaz A; Özçınar B; Özemir A; Çağlayan K; Ağcaoğlu O; Barbaros U; Salmaslioglu A; Erbil Y
    Int J Surg; 2013; 11(2):169-72. PubMed ID: 23274279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed Tomography in the Management of Adrenal Tumors: Does Size Still Matter?
    Azoury SC; Nagarajan N; Young A; Mathur A; Prescott JD; Fishman EK; Zeiger MA
    J Comput Assist Tomogr; 2017; 41(4):628-632. PubMed ID: 28107213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant and unclear histological findings in incidentalomas.
    Duenschede F; Bittinger F; Heintz A; Musholt T; Korenkov M; Kann P; Ewald P; Gockel I; Junginger T
    Eur Surg Res; 2008; 40(2):235-8. PubMed ID: 18032908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas.
    Shen WT; Sturgeon C; Clark OH; Duh QY; Kebebew E
    Surgery; 2004 Dec; 136(6):1129-37. PubMed ID: 15657566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization.
    Halefoglu AM; Yasar A; Bas N; Ozel A; Erturk SM; Basak M
    Acta Radiol; 2009 Nov; 50(9):1071-9. PubMed ID: 19863419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic adrenalectomy for primary and secondary malignant adrenal tumors.
    Tsuru N; Ushiyama T; Suzuki K
    J Endourol; 2005; 19(6):702-8; discussion 708-9. PubMed ID: 16053359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real indications for adrenalectomy in renal cell carcinoma.
    Moudouni SM; En-Nia I; Patard JJ; Manunta A; Guillé F; Lobel B
    Scand J Urol Nephrol; 2002; 36(4):273-7. PubMed ID: 12201919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can dynamic gadolinium-enhanced magnetic resonance imaging with chemical shift studies predict the status of adrenal masses?
    Prager G; Heinz-Peer G; Passler C; Kaczirek K; Schindl M; Scheuba C; Vierhapper H; Niederle B
    World J Surg; 2002 Aug; 26(8):958-64. PubMed ID: 12016475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy?
    Sturgeon C; Shen WT; Clark OH; Duh QY; Kebebew E
    J Am Coll Surg; 2006 Mar; 202(3):423-30. PubMed ID: 16500246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT-scan, MRI and image-guided FNA cytology of incidental adrenal masses.
    Lumachi F; Borsato S; Tregnaghi A; Basso SM; Marchesi P; Ciarleglio F; Fassina A; Favia G
    Eur J Surg Oncol; 2003 Oct; 29(8):689-92. PubMed ID: 14511619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical analysis of adrenal lesions larger than 5 cm in diameter (an analysis of 251 cases).
    Zhang Z; Wang L; Chen J; Li X; Liu D; Cao T; Yang X; Huang H; Wang X; Song X; Yang D; Wang J
    World J Surg Oncol; 2019 Dec; 17(1):220. PubMed ID: 31842905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants for malignancy in surgically treated adrenal lesions.
    Wright L; Nordenström E; Almquist M
    Langenbecks Arch Surg; 2012 Feb; 397(2):217-23. PubMed ID: 21935703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.